Italfarmaco Sa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ITALFARMACO SA, and what generic alternatives to ITALFARMACO SA drugs are available?
ITALFARMACO SA has one approved drug.
There is one US patent protecting ITALFARMACO SA drugs.
There are twenty-one patent family members on ITALFARMACO SA drugs in twenty-one countries.
Summary for Italfarmaco Sa
| International Patents: | 21 |
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Italfarmaco Sa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Italfarmaco Sa | TIGLUTIK KIT | riluzole | SUSPENSION;ORAL | 209080-001 | Sep 5, 2018 | AB | RX | Yes | Yes | 8,765,150 | ⤷ Sign Up | Y | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Italfarmaco Sa Drugs
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
